Siteman Cancer Center was part of this groundbreaking clinical trial that led to the approval of this new breakthrough immunotherapy. In fact, in 2017, Pedal the Cause donations funded another study led by Dr. DiPersio that is now exploring this very topic and hoping to expand CAR-T cell therapy treatment options every further!

Watch the full story here: